Main menu


South Korea approves the use of the "Moderna" vaccine against the Coronavirus

South Korea approved the use of the "Moderna" vaccine developed by the American pharmaceutical company to combat the Corona virus.

The South Korean "Yonhap" agency reported today, Friday, that the Korean Ministry of Food and Drug Safety decided to give the green light on the condition that Moderna provides a final report on the results of clinical studies after approval of its vaccine.

Thus, the "Moderna" vaccine becomes the fourth anti-Corona vaccine, approved in South Korea, after the vaccines AstraZeneca, Pfizer and Janssen.

A review team composed of experts concluded that the results of clinical trials of the "Moderna" vaccine have proven to be 94.1% effective in preventing Covid-19, which is sufficient for approval, and concluded that there are no major safety concerns.